<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Complement Altern Med</journal-id><journal-id journal-id-type="iso-abbrev">BMC Complement Altern Med</journal-id><journal-title-group><journal-title>BMC Complementary and Alternative Medicine</journal-title></journal-title-group><issn pub-type="epub">1472-6882</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6322278</article-id><article-id pub-id-type="publisher-id">2425</article-id><article-id pub-id-type="doi">10.1186/s12906-018-2425-0</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>In vitro evaluation of the activity of an essential oil from Pistacia vera L. variety Bronte hull against Candida sp.</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>D&#x02019;Arrigo</surname><given-names>Manuela</given-names></name><address><email>mdarrigo@unime.it</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Bisignano</surname><given-names>Carlo</given-names></name><address><email>cbisignano@unime.it</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Irrera</surname><given-names>Pierangela</given-names></name><address><email>pierangelairrera@virgilio.it</email></address><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Smeriglio</surname><given-names>Antonella</given-names></name><address><email>asmeriglio@unime.it</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Zagami</surname><given-names>Roberto</given-names></name><address><email>rzagami@unime.it</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Trombetta</surname><given-names>Domenico</given-names></name><address><email>dtrombetta@unime.it</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Romeo</surname><given-names>Orazio</given-names></name><address><email>oromeo@unime.it</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5663-3702</contrib-id><name><surname>Mandalari</surname><given-names>Giuseppina</given-names></name><address><email>gmandalari@unime.it</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2178 8421</institution-id><institution-id institution-id-type="GRID">grid.10438.3e</institution-id><institution>Department of Chemical, Biological, Pharmaceutical and Environmental Science, </institution><institution>University of Messina, </institution></institution-wrap>Via SS. Annunziata, 98168 Messina, Italy </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2178 8421</institution-id><institution-id institution-id-type="GRID">grid.10438.3e</institution-id><institution>Department of Biomedical, Dental, Morphological and Functional Images Sciences, </institution><institution>University of Messina, </institution></institution-wrap>Via C. Valeria, 98125 Messina, Italy </aff><aff id="Aff3"><label>3</label>Fondazione Imbesi, Messina, Italy </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.419419.0</institution-id><institution>IRCCS Centro, </institution></institution-wrap>Neurolesi Bonino-Pulejo, S.S. 113 Via Palermo C.da Casazza, 98123 Messina, Italy </aff></contrib-group><pub-date pub-type="epub"><day>7</day><month>1</month><year>2019</year></pub-date><pub-date pub-type="pmc-release"><day>7</day><month>1</month><year>2019</year></pub-date><pub-date pub-type="collection"><year>2019</year></pub-date><volume>19</volume><elocation-id>6</elocation-id><history><date date-type="received"><day>28</day><month>9</month><year>2018</year></date><date date-type="accepted"><day>26</day><month>12</month><year>2018</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s). 2019</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p id="Par1"><italic>Candida</italic> sp. represent the most common cause of fungal infections worldwide. In the present work, we have evaluated the activity of an essential oil extracted from pistachio hulls against a number of standard and clinical strains of <italic>Candida</italic> sp.</p></sec><sec><title>Methods</title><p id="Par2"><italic>C. albicans</italic> ATCC 64550, <italic>C. parapsilosis</italic> ATCC 22019, 4 clinical strains of <italic>C. albicans</italic>, 3 clinical strains of <italic>C. parapsilosis</italic> and 3 clinical strains of <italic>C. glabrata</italic> were used. All clinical isolates were identified by species-specific PCR-based methods. Susceptibility studies were performed using pistachio hull essential oil alone or in combination with antifungal compounds. The interactions between pistachio hull essential oil and selected antifungal compounds were also evaluated using the checkerboard method and the mechanisms of interaction investigated by droplet size distribution.</p></sec><sec><title>Results</title><p id="Par3">Pistachio hull essential oil was fungicidal at the concentrations between 2.50 and 5.0&#x02009;mg/ml. D-limonene and 3-Carene were the components with major activity. An antagonistic effect was observed with all combinations tested.</p></sec><sec><title>Conclusion</title><p id="Par4">The antifungal activity of pistachio hull essential oil could be used to help control resistance in <italic>Candida</italic> species. More studies need to be performed to elucidate the mechanisms responsible for the activity of pistachio hull essential oil.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Pistachio</kwd><kwd>Essential oil</kwd><kwd><italic>Candida</italic> sp.</kwd><kwd>Antifungal</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100008908</institution-id><institution>Universit&#x000e0; degli Studi di Messina</institution></institution-wrap></funding-source></award-group></funding-group><funding-group><award-group><funding-source><institution>Fondazione Imbesi Messina </institution></funding-source></award-group></funding-group><funding-group><award-group><funding-source><institution>Italian Ministry of Health</institution></funding-source><award-id>GR-2011-02347606</award-id><principal-award-recipient><name><surname>Romeo</surname><given-names>Orazio</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2019</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p id="Par8">Over the last few years, incidence of <italic>Candida spp</italic>. infections have significantly increased, with higher mortality rates and hospital acquired infections [<xref ref-type="bibr" rid="CR1">1</xref>]. In immunocompetent subjects, <italic>Candida spp</italic>. are generally responsible for mucosal infections, including thrush and vaginitis, which can lead to invasive candidiasis in immunocompromised patients, with emerging species becoming multi-drug resistant [<xref ref-type="bibr" rid="CR2">2</xref>]. Due to the increased resistance to antifungal compounds, more effort is focused on natural drugs, to use alone or in combination with existing antimicrobials [<xref ref-type="bibr" rid="CR3">3</xref>]. Essential oils (EOs) are a complex mixture of hydrocarbons and oxygenated hydrocarbons which have recently gained interest due to their antimicrobial potential against human pathogens and their protective role regarding cardiovascular and neurological diseases, diabetes and cancer [<xref ref-type="bibr" rid="CR4">4</xref>].</p><p id="Par9">Gucwa et al. [<xref ref-type="bibr" rid="CR5">5</xref>] have recently reported the activity of EOs from <italic>Thymus vulgaris</italic>, <italic>Citrus limonum</italic>, <italic>Pelargonium graveolens</italic>, <italic>Cinnamomum cassia</italic>, <italic>Ocimum basilicum</italic> and <italic>Eugenia caryophyllus</italic> against 183 clinical isolates of <italic>C. albicans</italic> and 76 isolates of <italic>C. glabrata</italic>. The chemical composition and antifungal effects of the <italic>Eugenia uniflora</italic> EO were recently investigated against <italic>C. albicans</italic>, <italic>C. krusei</italic> and <italic>C. tropicalis</italic> standard strains [<xref ref-type="bibr" rid="CR6">6</xref>].</p><p id="Par10">We have previously characterised the nutraceutical, antioxidant and cytoprotective activity of pistachio (<italic>Pistacia vera</italic> L., variety Bronte) hulls extracts: they are rich in phenols, including flavonols, phenolic acid, and flavan-3-ols, and anthocyanins, such as cyanidyn-3-<italic>O</italic>-galactoside [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>]. Furthermore, the antimicrobial activity of the EO from pistachio hulls against Gram-positive and Gram-negative strains, both American Type Culture Collection (ATCC) and clinical isolates, was investigated [<xref ref-type="bibr" rid="CR9">9</xref>].</p><p id="Par11">In the present study, the EO extracted from pistachio hulls was tested against standard and clinical strains of <italic>C. albicans</italic>, <italic>C. glabrata</italic> and <italic>C. parapsilopsis</italic>, both alone and in combination with antifungal drugs. The molecular identification of the clinical strains is also reported.</p></sec><sec id="Sec2"><title>Methods</title><sec id="Sec3"><title>Plant material</title><p id="Par12">The hulls of ripe pistachio nuts (<italic>Pistacia vera</italic> L., Bronte variety) were collected in end-August 2017 by a local farmer in Bronte (Catania, Italy) and identified by Prof. Laura Cornara (Botanist at the Dept. DISTAV of the University of Genoa, Italy). A voucher specimen has been deposited in the ChiBioFarAm Department, University of Messina (Messina, Italy).</p></sec><sec id="Sec4"><title>Essential oil isolation and characterization</title><p id="Par13">The pistachio hull essential oil was isolated by hydrodistillation using a Clevenger apparatus and characterized by GC-FID and GC-MS analysis according to Smeriglio et al. [<xref ref-type="bibr" rid="CR9">9</xref>].</p></sec><sec id="Sec5"><title>Origin and identification of the Candida strains</title><p id="Par14">All clinical <italic>Candida</italic> isolates tested in this study were recovered at the IRCCS Centro Neurolesi &#x0201c;Bonino-Pulejo&#x0201d; hospital, Messina, Italy, during a surveillance program funded by the Italian Ministry of Health for the prevention and control of healthcare<italic>-</italic>associated fungal infections (project code: GR-2011-02347606). These isolates were obtained from blood samples of patients with acquired brain injuries. Initially, all strains were presumptively identified using <italic>Candida</italic> medium (Becton Dickinson, Italy) and Vitek 2 yeast identification system (bioM&#x000e9;rieux, Italy) following manufacturer&#x02019;s recommendations. The identity of the yeast isolates was subsequently confirmed by using simple and rapid species-specific PCR-based methods according to previous studies [<xref ref-type="bibr" rid="CR10">10</xref>&#x02013;<xref ref-type="bibr" rid="CR12">12</xref>]. Briefly, total genomic DNA was extracted from <italic>Candida</italic> cells using the glass-beads disruption method followed by conventional phenol<italic>/</italic>chloroform<italic>/isoamyl</italic> alcohol purification [<xref ref-type="bibr" rid="CR13">13</xref>]. I<italic>n vitro</italic> amplifications (total volume 50&#x02009;&#x003bc;l) were carried out separately for each strain using the Dream Taq Green PCR Master Mix (Thermo Fischer scientific, Milan, Italy), a ready-to-use solution containing all reagents required for PCR to which were only added the genomic DNA template (0.5&#x02009;&#x003bc;g) and the specific primers (0.5&#x02009;&#x003bc;M each), depending on the assay type (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). The amplicons were analyzed by 1.5% agarose gel electrophoresis for determining the expected DNA fragment sizes for <italic>C. albicans</italic>, <italic>C. parapsilosis</italic> and <italic>C. glabrata</italic> (Table <xref rid="Tab1" ref-type="table">1</xref>) by excluding the probable cryptic presence of phylogenetically closely related species.<table-wrap id="Tab1"><label>Table 1</label><caption><p>PCR primers used for molecular identification of <italic>Candida</italic> species tested in this study</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Molecular method</th><th>Species identified</th><th>Primer name</th><th>Sequence (5&#x02032;&#x02009;&#x02192;&#x02009;3&#x02032;)</th><th>Amplicon size</th><th>Reference</th></tr></thead><tbody><tr><td rowspan="2">Singleplex PCR</td><td rowspan="2">
<italic>C. albicans</italic>
</td><td>CR-f</td><td>GCTACCACTTCAGAATCATCATC</td><td rowspan="2">~&#x02009;960&#x02009;bp</td><td rowspan="2">Romeo and Criseo, 2008</td></tr><tr><td>CR-r</td><td>GCACCTTCAGTCGTAGAGACG</td></tr><tr><td rowspan="4">Multiplex PCR</td><td rowspan="4">
<italic>C. glabrata</italic>
</td><td>UNI-5,8S</td><td>ACCAGAGGGCGCAATGTG</td><td rowspan="4">~&#x02009;397&#x02009;bp</td><td rowspan="4">Romeo et al., 2009</td></tr><tr><td>GLA-f</td><td>CGGTTGGTGGGTGTTCTGC</td></tr><tr><td>NIV-f</td><td>AGGGAGGAGTTTGTATCTTTCAAC</td></tr><tr><td>BRA-f</td><td>GGGACGGTAAGTCTCCCG</td></tr><tr><td rowspan="5">Multiplex PCR</td><td rowspan="5">
<italic>C. parapsilosis</italic>
</td><td>mCPF</td><td>TTTGCTTTGGTAGGCCTTCTA</td><td rowspan="5">~&#x02009;171&#x02009;bp</td><td rowspan="5">Asadzadeh et al., 2015</td></tr><tr><td>mCOF</td><td>TAAGTCAACTGATTAACTAAT</td></tr><tr><td>mCMF</td><td>AACTGCAATCCTTTTCTTTCTA</td></tr><tr><td>mLEF</td><td>TACAGAATTTTGAGAATTGTG</td></tr><tr><td>mCPCR</td><td>AATATCTGCAATTCATATTACT</td></tr></tbody></table></table-wrap></p></sec><sec id="Sec6"><title>Microbial strains and culture conditions</title><p id="Par15">The following strains were used for the antifungal testing: <italic>C. albicans</italic> ATCC 64550, <italic>C. parapsilosis</italic> ATCC 22019, 4 clinical strains of <italic>C. albicans</italic> (12, 13, 16, 17), 3 clinical strains of <italic>C. parapsilosis</italic> (26, 30, 34), 3 clinical strains of <italic>C. glabrata</italic> (9, 25, 33). Strains were grown in RPMI 1640 (Sigma, Italy) at 30&#x02009;&#x000b0;C for 24&#x02009;h. For minimal fungicidal determination and killing curves, Sabouraud Dextrose Agar (Oxoid) was used.</p></sec><sec id="Sec7"><title>Susceptibility studies</title><p id="Par16">For the susceptibility studies, the EO from pistachio hull was dissolved in DMSO at the concentration of 10&#x02009;mg/ml. The minimum inhibitory concentration (MIC) and the minimum fungicidal concentration (MFC) of pistachio hull EO and the antifungal compounds voriconazole, fluconazole and caspofungin (Sigma Aldrich, Italy) against the strains reported above were determined following the CLSI guidelines (M27-A3 2008, [<xref ref-type="bibr" rid="CR14">14</xref>]). Serial dilutions were performed in RPMI 1640 at concentrations between 16 and 0.0156&#x02009;&#x003bc;g&#x02009;ml<sup>&#x02212;&#x02009;1</sup> (voriconazole), 64 and 0.0625&#x02009;&#x003bc;g&#x02009;ml<sup>&#x02212;&#x02009;1</sup> (fluconazole), 2 and 0.00195&#x02009;&#x003bc;g&#x02009;ml<sup>&#x02212;&#x02009;1</sup> (caspofungin) and 10 and 0.0049% mg/ml (pistachio hull essential oil). MFC (minimal fungicidal concentration) for the pistachio hull EO was determined transferring each clear sample (20&#x02009;&#x003bc;L) on agar plate incubated at 30&#x02009;&#x000b0;C for 48&#x02009;h. The MFC was defined as the lowest extract concentration that killed 99.9% of the final inocula after 24-48&#x02009;h incubation.</p><p id="Par17">In the combination assays, the &#x02018;checkerboard&#x02019; procedure was followed [<xref ref-type="bibr" rid="CR15">15</xref>] in order to test the efficacy of the combination EO/antifungal compounds against all tested strains. This method allows varying the concentrations of each antimicrobial along the different axes, thus ensuring that each well contained a different combination [<xref ref-type="bibr" rid="CR16">16</xref>]. MIC data for pistachio hull EO and each antifungal compound were converted into fractional inhibitory concentration (FIC), defined as the ratio of the concentration of the antimicrobial in an inhibitory concentration with a second compound to the concentration of the antimicrobial by itself.</p><p id="Par18">FICI&#x02009;=&#x02009;MIC of A with B/MIC of A.</p><p id="Par19">In order to identify the active antifungal components of the pistachio hull EO, MICs and MFCs were also determined with &#x003b1;-pinene, &#x003b1;-terpineol, camphene, D-limonene and 3-carene as well as the mix of these compounds at the concentrations found in the EO against <italic>C. albicans</italic> strain 16, <italic>C. glabrata</italic> strain 9 and <italic>C. parapsilosis</italic> strain 26.</p><p id="Par20">All experiments were performed in triplicate on three independent days.</p></sec><sec id="Sec8"><title>Time kill curves</title><p id="Par21">Tubes containing each antifungal compound at concentrations corresponding to 1, 1/2 and 1/4 x MIC were inoculated with a suspension of <italic>C. glabrata</italic> strain 9, <italic>C. albicans</italic> strain 16 and <italic>C. parapsilosis</italic> strain 26, yielding a final fungal density of 5&#x02009;&#x000d7;&#x02009;10<sup>5</sup>&#x02009;CFU/ml and then incubated at 30&#x02009;&#x000b0;C in a shaking incubator. A growth control was also performed. Samples for viable counting were withdrawn at 0, 1, 2, 4, 8 and 24&#x02009;h and, if necessary, diluted in fresh medium. At least four dilutions of each sample were spread on agar plates (Sabouraud Dextrose Agar), incubated at 30&#x02009;&#x000b0;C and counted after 48&#x02009;h.</p></sec><sec id="Sec9"><title>Droplet size and size distribution</title><p id="Par22">Size distribution and average diameter of emulsions&#x02019; droplets were determined by dynamic light scattering on a Malvern 4700 submicron analyzer (Malvern Instruments Inc., Worcestershire, U.K.). Distilled water was used as dispersant to avoid effects of multiple scattering, dispersion, and interactions between droplets. The cumulative mean diameter (z-average) and polydispersity index (PdI) were used to describe droplet average size and size distribution, respectively.</p></sec></sec><sec id="Sec10"><title>Results</title><sec id="Sec11"><title>Antifungal activity of pistachio hull EO</title><p id="Par23">MICs and MFCs values for pistachio hull EO and three antifungal compounds were determined (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>). Results of negative controls using DMSO as a solvent at the concentration of 1% (<italic>v</italic>/v) indicated the complete absence of inhibition of all the strains tested (data not shown). Pistachio hull EO was active against all strains tested, <italic>C. parapsilosis</italic> strains being the most sensitive (complete inhibition achieved with a concentration of 1.25&#x02013;2.50&#x02009;mg/ml), followed by <italic>C. glabrata</italic> strains (complete inhibition achieved with a concentration of 1.25&#x02013;5.0&#x02009;mg/ml) and <italic>C. albicans</italic> strains (complete inhibition achieved with a concentration of 5.0&#x02009;mg/ml). The effect of pistachio hull EO was fungicidal against all tested strains. Interestingly, all clinical strains of <italic>C. albicans</italic> and1 strain of <italic>C. glabrata</italic> (strain 33) were resistant to both voriconazole and fluconazole.<table-wrap id="Tab2"><label>Table 2</label><caption><p>MICs and MFCs of Pistachio Essential Oil (expressed as mg/ml) and antifungal compounds (expressed as &#x000b5;g/ml) against <italic>Candida sp</italic>.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">STRAIN</th><th colspan="2">VORICONAZOLE</th><th colspan="2">FLUCONAZOLE</th><th colspan="2">CASPOFUNGIN</th><th colspan="2">Pistachio Essential Oil</th></tr><tr><th>MIC</th><th>MFC</th><th>MIC</th><th>MFC</th><th>MIC</th><th>MFC</th><th>MIC</th><th>MFC</th></tr></thead><tbody><tr><td><italic>Candida glabrata</italic> strain <italic>9</italic></td><td>0.015&#x02013;0.031</td><td>1</td><td>8&#x02013;8</td><td>8</td><td>0.015&#x02013;0.031</td><td>1</td><td>2.5&#x02013;5.0</td><td>5.0</td></tr><tr><td><italic>Candida glabrata</italic> strain <italic>25</italic></td><td>0.015&#x02013;0.031</td><td>0.031</td><td>0.25&#x02013;0.5</td><td>0.5</td><td>0.125&#x02013;0.25</td><td>1</td><td>5.0</td><td>5.0</td></tr><tr><td><italic>Candida glabrata</italic> strain <italic>33</italic></td><td>&#x0003e;&#x02009;16</td><td char="&#x000d7;" align="char">/</td><td>&#x0003e;&#x02009;64</td><td>/</td><td>0.125&#x02013;0.25</td><td>1</td><td>1.25&#x02013;2.50</td><td>5.0</td></tr><tr><td><italic>Candida parapsilosis</italic> strain <italic>26</italic></td><td>0.015&#x02013;0.031</td><td char="&#x000d7;" align="char">0.031</td><td>0.5&#x02013;1</td><td>1</td><td>0.5&#x02013;0.25</td><td>0.5</td><td>1.25&#x02013;2.50</td><td>2.50</td></tr><tr><td><italic>Candida parapsilosis</italic> strain <italic>30</italic></td><td>0.015&#x02013;0.031</td><td char="&#x000d7;" align="char">0.031</td><td>0.5&#x02013;1</td><td>1</td><td>0.125&#x02013;0.25</td><td>0.5</td><td>1.25&#x02013;2.50</td><td>2.50</td></tr><tr><td><italic>Candida parapsilosis</italic> strain <italic>34</italic></td><td>0.125&#x02013;0.25</td><td>0.25</td><td>8&#x02013;4</td><td>8</td><td>0.25&#x02013;0.5</td><td>0.5</td><td>1.25&#x02013;2.50</td><td>2.50</td></tr><tr><td><italic>Candida albicans</italic> strain <italic>12</italic></td><td>&#x0003e;&#x02009;16</td><td>/</td><td>&#x0003e;&#x02009;64</td><td>/</td><td>0.0075&#x02013;0.015</td><td>0.015</td><td>5.0</td><td>5.0</td></tr><tr><td><italic>Candida albicans</italic> strain <italic>13</italic></td><td>&#x0003e;&#x02009;16</td><td char="&#x000d7;" align="char">/</td><td>&#x0003e;&#x02009;64</td><td>/</td><td>&#x02264;0.0019</td><td>/</td><td>5.0</td><td>5.0</td></tr><tr><td><italic>Candida albicans</italic> strain <italic>16</italic></td><td>&#x0003e;&#x02009;16</td><td char="&#x000d7;" align="char">/</td><td>&#x0003e;&#x02009;64</td><td>/</td><td>0.015</td><td>0.015</td><td>5.0</td><td>5.0</td></tr><tr><td><italic>Candida albicans</italic> strain <italic>17</italic></td><td>&#x0003e;&#x02009;16</td><td char="&#x000d7;" align="char">/</td><td>&#x0003e;&#x02009;64</td><td>/</td><td>&#x02264;0.0019</td><td>/</td><td>5.0</td><td>5.0</td></tr><tr><td>
<italic>Candida albicans ATCC 64550</italic>
</td><td>1</td><td>1</td><td>32</td><td>32</td><td>0.0625</td><td>0.0625</td><td>2.50&#x02013;5.0</td><td>5.0</td></tr><tr><td>
<italic>Candida parapsilosis ATCC 22019</italic>
</td><td>0.062</td><td>0.062</td><td>4</td><td>8</td><td>1&#x02013;2</td><td>1</td><td>1.25&#x02013;2.50</td><td>2.50</td></tr></tbody></table><table-wrap-foot><p><italic>MIC</italic> Minimum Inhibitory Concentration, <italic>MFC</italic> Minimum Fungicidal Concentration</p></table-wrap-foot></table-wrap></p><p id="Par24">In the combination assays, the FIC index calculated for pistachio hull EO and each antifungal compound was &#x0003e;&#x02009;4 against all tested strains. Although the interpretation of the FIC indices depends on which definition is used, here we have interpreted the index as synergistic if the FIC index is &#x02264;0.5, additive or indifferent if &#x0003e;&#x02009;0.5 but &#x02264;4 and antagonistic if &#x0003e;&#x02009;4 [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>].</p><p id="Par25">Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref> reports the MIC data for the pure compounds present in pistachio hull EO and the mix of the most representative compounds in the proportion found in the oil. Amongst the pure molecules, 3-carene was the most effective against the three representative tested strains, followed by D-limonene. No activity was detected with &#x003b1;-pinene, &#x003b1;-terpineol and camphene. Interestingly, the mix of compounds was effective against all tested strains, indicating a possible synergistic interaction amongst the individual compounds. As shown in Table <xref rid="Tab2" ref-type="table">2</xref>, <italic>C. albicans</italic> strain 16 was the most resistant, followed by <italic>C. glabrata</italic> strain 9 and <italic>C. parapsilosis</italic> strain 26.<table-wrap id="Tab3"><label>Table 3</label><caption><p>MICs of pistachio hull EO pure compounds and their mix <italic>C. albicans</italic> strain 16, <italic>C. glabrata</italic> strain 9 and <italic>C. parapsilosis</italic> strain 26</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Strain</th><th>&#x003b1;-pinene</th><th>&#x003b1;-terpineol</th><th>Camphene</th><th>D-limonene</th><th>3-Carene</th><th>Mix</th></tr></thead><tbody><tr><td><italic>C. albicans</italic> strain 16</td><td>&#x0003e;&#x02009;1000</td><td>&#x0003e;&#x02009;1000</td><td>&#x0003e;&#x02009;1000</td><td>125&#x02013;250</td><td>62.50&#x02013;125</td><td>250</td></tr><tr><td><italic>C. glabrata</italic> strain 9</td><td>&#x0003e;&#x02009;1000</td><td>&#x0003e;&#x02009;1000</td><td>&#x0003e;&#x02009;1000</td><td>62.50</td><td>62.50&#x02013;125</td><td>125&#x02013;250</td></tr><tr><td><italic>C. parapsilosis</italic> strain 26</td><td>&#x0003e;&#x02009;1000</td><td>&#x0003e;&#x02009;1000</td><td>&#x0003e;&#x02009;1000</td><td>31.25&#x02013;62.50</td><td>15.65&#x02013;31.25</td><td>62.5</td></tr></tbody></table><table-wrap-foot><p>Values are expressed as &#x003bc;g/ml and represent the mean of three determinations. Standard errors between these three determinations are negligible</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec12"><title>Fungal killing</title><p id="Par26">Concentration-dependent killing was observed with pistachio hull EO against all tested strains (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref> a-c). A good fungicidal effect was achieved after 2&#x02009;h exposure against <italic>C. parapsilosis</italic> strain 26 at the concentration of 1 x MIC, whereas the same effect was achieved against <italic>C. albicans</italic> strain 16 and <italic>C. glabrata</italic> strain 9 after 8&#x02009;h exposure. Concentrations of &#x000bd; MIC and &#x000bc; MIC exerted a fungistatic effect against all tested strains. As reported in Tables&#x000a0;<xref rid="Tab1" ref-type="table">1</xref> and <xref rid="Tab2" ref-type="table">2</xref>, <italic>C. albicans</italic> strain 16 was the most resistant.<fig id="Fig1"><label>Fig. 1</label><caption><p>Killing curves for pistachio hull EO against <italic>C. albicans</italic> strain 16 (<bold>a</bold>), <italic>C. glabrata</italic> strain 9 (<bold>b</bold>) and <italic>C. parapsilosis</italic> strain 26 (<bold>c</bold>). Control, &#x02666;; 1/4xMIC, &#x000d7;; 1/2xMIC, &#x025b2;; 1xMIC, &#x025a0;. Mean of three experiments. MIC&#x02009;=&#x02009;minimum inhibitory concentration</p></caption><graphic xlink:href="12906_2018_2425_Fig1_HTML" id="MO1"/></fig></p></sec><sec id="Sec13"><title>Light scattering</title><p id="Par27">Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref> summarizes the effect of the essential oil (EO) on the droplet size and emulsion polydispersity (PdI) in bacteria culture medium, taking into account both the hydrodynamic then the distribution width of this complex system. Both parameters are calculated according to the International Standard on dynamic light scattering, ISO 22412 [<xref ref-type="bibr" rid="CR18">18</xref>]. The partition coefficient (logP) of the three antifungals under study was calculated by miLogP2.2 software [<xref ref-type="bibr" rid="CR19">19</xref>].<table-wrap id="Tab4"><label>Table 4</label><caption><p>Effect of the Pistachio Essential oil on droplet size (Z-Average Diameter) and emulsion polydispersity (Polydispersity index) in yeast culture medium</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Preparation</th><th>Z-Average Diameter<break/>(nm)</th><th>Polydispersity index</th><th>LogP</th></tr></thead><tbody><tr><td>RPMI+DMSO</td><td>881.4&#x000a0;&#x000b1;&#x000a0;1.8</td><td>0.836&#x000a0;&#x000b1;&#x000a0;0.011</td><td>&#x02013;</td></tr><tr><td>Fluconazole</td><td>1570.0&#x000a0;&#x000b1;&#x000a0;2.1</td><td>1.0&#x000a0;&#x000b1;&#x000a0;0.012</td><td>&#x02212;0.12</td></tr><tr><td>Voriconazole</td><td>2316.0&#x000a0;&#x000b1;&#x000a0;2.3</td><td>1.0&#x000a0;&#x000b1;&#x000a0;0.011</td><td>1.49</td></tr><tr><td>Caspofungin</td><td>531.3&#x000a0;&#x000b1;&#x000a0;1.6</td><td>0.679&#x000a0;&#x000b1;&#x000a0;0.010</td><td>&#x02212;4.59</td></tr><tr><td>EO</td><td>2151.0&#x000a0;&#x000b1;&#x000a0;2.2</td><td>1.0&#x000a0;&#x000b1;&#x000a0;0.012</td><td>&#x02013;</td></tr><tr><td>EO&#x02009;+&#x02009;Fluconazole</td><td>847.5&#x000a0;&#x000b1;&#x000a0;2.3</td><td>0.688&#x000a0;&#x000b1;&#x000a0;0.008</td><td>&#x02013;</td></tr><tr><td>EO&#x02009;+&#x02009;Voriconazole</td><td>343.7&#x000a0;&#x000b1;&#x000a0;1.5</td><td>0.426&#x000a0;&#x000b1;&#x000a0;0.007</td><td>&#x02013;</td></tr><tr><td>EO&#x02009;+&#x02009;Caspofungin</td><td>690.1&#x000a0;&#x000b1;&#x000a0;2.1</td><td>0.538&#x000a0;&#x000b1;&#x000a0;0.004</td><td>&#x02013;</td></tr></tbody></table><table-wrap-foot><p>Theoretical logP value of the three antifungals are reported. Each measurement represents mean&#x02009;&#x000b1;&#x02009;standard deviation (<italic>n</italic>&#x02009;=&#x02009;3)</p></table-wrap-foot></table-wrap></p><p id="Par28">The droplet size distribution of the different emulsions revealed the lack of a droplet population below 100&#x02009;nm, while a droplet population with a diameter above than 300&#x02009;nm was detected.</p><p id="Par29">Pistachio hull EO, fluconazole and voriconazole showed an average diameter greater than 1500&#x02009;nm and a PdI equal to 1.0, whereas caspofungin showed an average diameter around 500&#x02009;nm and a PdI of 0.679.</p></sec></sec><sec id="Sec14"><title>Discussion</title><p id="Par30">The present study has demonstrated that an essential oil extracted from pistachio hulls was effective against clinical strains of <italic>Candida</italic>. The dramatic rise in antimicrobial resistance is now considered a major health treat, with an estimated 700,000 people dying every year from antibiotic, antiviral, antifungal and antimalarial resistance infections [<xref ref-type="bibr" rid="CR20">20</xref>]. Therefore, natural products have become an important source for drug development. Geraniol has been tested against <italic>C. albicans</italic> species and its mechanism of action has been elucidated [<xref ref-type="bibr" rid="CR21">21</xref>]. Ebani et al. [<xref ref-type="bibr" rid="CR22">22</xref>] have recently demonstrated the activity of five essential oils (star anise, basil, oregano, clary sage and thymus) against multidrug-resistant strains of <italic>Escherichia coli</italic>, <italic>Enterococcus</italic> spp., <italic>C. albicans</italic> and <italic>C. famata</italic> responsible for urinary tract infections. The pistachio hull essential oil tested in the present work was effective against <italic>Candida sp</italic>., whereas polyphenol-rich extracts from pistachios (natural raw shelled and roasted salted pistachios) and white grape juice used in our previous investigations were not effective against yeasts [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR24">24</xref>]. Amongst the major components identified in the pistachio hull EO, D-limonene and 3-carene were effective against <italic>C. albicans</italic> strain 16, <italic>C. glabrata</italic> strain 9 and <italic>C. parapsilosis</italic> strain 26 (Table <xref rid="Tab3" ref-type="table">3</xref>). This is in agreement with the demonstrated antifungal activity against <italic>C. albicans</italic> of the <italic>Chamaecyparis nootkatensis</italic> essential oil [<xref ref-type="bibr" rid="CR25">25</xref>].</p><p id="Par31">It is known that plant natural products mostly exert their antifungal effects by membrane-active mechanism and synergistic effects can be found between different classes of plant products as well as between natural products and azoles [<xref ref-type="bibr" rid="CR26">26</xref>]. Bioactive compounds present in natural products, such as EOs, may interact to produce synergistic, additive or antagonistic effects. Synergistic interactions could result in increased efficacy, or reduce effective doses, therefore reducing the likelihood of adverse effects [<xref ref-type="bibr" rid="CR27">27</xref>]. We have previously shown that pairwise combinations of polyphenols present in almonds (protocatechuic acid, naringenin and epicatechin) showed both synergistic and indifferent interactions against <italic>Salmonella enterica</italic> and <italic>Staphylococcus aureus</italic> [<xref ref-type="bibr" rid="CR28">28</xref>].</p><p id="Par32">In the present study, the interactions between pistachio hull EO and the selected antifungal compounds were antagonistic (FIC index &#x0003e;&#x02009;4) and droplet size distribution was used to investigate the mechanisms responsible for such interactions. PdI values close to 1.0 are indicative of polydispersed systems [<xref ref-type="bibr" rid="CR29">29</xref>], whereas values close to 0.6 suggesting monomodal systems. Interestingly, amongst the antifungal used, caspofungin is the most hydrophilic one as shown by its logP value of &#x02212;&#x02009;4.59. This property is due to the numerous hydroxyl groups, which makes it able to donate and accept 16 and 18 hydrogen bonds respectively (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>c). This allows an excellent dispersion of the molecule in the aqueous medium leading to a homogeneous droplet system. In fact, addition of pistachio hull EO to the system did not lead to substantial changes in the average diameter of the droplets or in the PdI of the culture medium. On the contrary, addition of the EO to the system containing either fluconazole or voriconazole (Fig. <xref rid="Fig2" ref-type="fig">2</xref>a and b) led to a system stabilization as highlighted by the decrease both of the droplet diameter average then of the PdI. These two drugs, which only differ for the presence of one more fluorine atom on position 5 of the pyrimidine ring and a 2-butanol as aliphatic chain instead of 2-propanol in the voriconazole (Fig. <xref rid="Fig2" ref-type="fig">2</xref>b), are less hydrophilic and possess a smaller steric encumbrance compared to caspofungin (Table <xref rid="Tab4" ref-type="table">4</xref>). In fact, fluconazole and voriconazole are able to donate a single hydrogen bond and to accept 7 and 8 hydrogen bonds, respectively. Therefore, on the contrary of which happens in presence of caspofungin, fluconazole and voriconazole are not able to stabilize alone the system but at the same time, the addition of EO, which behaves like a non-ionic surfactant, stabilise the emulsions by reducing interfacial tension and promote steric repulsion between droplets [<xref ref-type="bibr" rid="CR30">30</xref>]. The main mechanism for emulsion destabilization is actually associated with Ostwald ripening, which induces formation of larger droplets [<xref ref-type="bibr" rid="CR31">31</xref>]. PdI values range from 1.0 to 0.688 and 0.426 for EO&#x02009;+&#x02009;fluconazole and EO&#x02009;+&#x02009;voriconazole, respectively, reflecting the homogeneity in the droplet size distribution of the new stabilized system. These events could be responsible for the difficulty of both EO and drugs to carry out their antifungal activity against <italic>Candida</italic> strains, which results in an antagonistic effect.<fig id="Fig2"><label>Fig. 2</label><caption><p>Structural formula of fluconazole (<bold>a</bold>), voriconazole (<bold>b</bold>) and caspofungin (<bold>c</bold>)</p></caption><graphic xlink:href="12906_2018_2425_Fig2_HTML" id="MO2"/></fig></p><p id="Par33">However, considering the interactions between EOs and antimicrobials, it is important to take into account the complex composition of EOs, which makes it rather difficult to predict mode of interaction, especially since the pharmacokinetic profiles are not elucidated. Therefore, the use of individual bioactives could be more commercially viable, with easier standardization in terms of activity, mechanisms of action, pharmacodynamics and pharmacokinetics.</p></sec><sec id="Sec15"><title>Conclusions</title><p id="Par34">In summary, the results of the present study showed that bioactives present in pistachio hulls EO are effective against a range of clinical strains of <italic>Candida</italic>, some of whom resistant to antifungal compounds. Further studies need to be performed to elucidate the mechanisms responsible for the activity and the interactions with antifungal compounds.</p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>EO</term><def><p id="Par5">Essential oil</p></def></def-item><def-item><term>MFC</term><def><p id="Par6">Minimum Fungicidal Concentration</p></def></def-item><def-item><term>MIC</term><def><p id="Par7">Minimum Inhibitory Concentration</p></def></def-item></def-list></glossary><ack><title>Acknowledgements</title><p>Not applicable.</p><sec id="FPar1"><title>Funding</title><p id="Par35">This work has been funded by the University of Messina and Fondazione Imbesi (Messina, Italy). The funding body was not involved in the design of the study and collection, analysis, and interpretation of data, as well as and in writing the manuscript.</p><p id="Par36">The <italic>Candida</italic> strains tested in this work were from a project funded by a grant from the Italian Ministry of Health to Orazio Romeo (Young Investigator Project, code: GR-2011-02347606).</p></sec><sec id="FPar2"><title>Availability of data and materials</title><p id="Par37">Data can be accessed at the University of Messina.</p></sec></ack><notes notes-type="author-contribution"><title>Authors&#x02019; contributions</title><p>CB, MD, GM conceived the study, OR provided clinical <italic>Candida</italic> strains and performed molecular identification, PI, CB, MD performed the antimicrobial assays, AS and DT carried out the essential oil extraction and characterization, RZ performed the light scattering experiments. All authors read and approved the final version of the manuscript.</p></notes><notes notes-type="COI-statement"><sec id="FPar3"><title>Ethics approval and consent to participate</title><p>Not applicable.</p></sec><sec id="FPar4"><title>Consent for publication</title><p>Not applicable.</p></sec><sec id="FPar5"><title>Competing interests</title><p>The authors declared that they have no competing interests.</p></sec><sec id="FPar6"><title>Publisher&#x02019;s Note</title><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></sec></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yapar</surname><given-names>N</given-names></name></person-group><article-title>Epidemiology and risk factors for invasive candidiasis</article-title><source>Ther Clin Risk Manag</source><year>2014</year><volume>10</volume><fpage>95</fpage><lpage>105</lpage><pub-id pub-id-type="doi">10.2147/TCRM.S40160</pub-id><pub-id pub-id-type="pmid">24611015</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colombo</surname><given-names>AL</given-names></name><name><surname>J&#x000fa;nior</surname><given-names>JNA</given-names></name><name><surname>Guinea</surname><given-names>J</given-names></name></person-group><article-title>Emerging multidrug-resistant Candida species</article-title><source>Curr Opin Infect Dis</source><year>2017</year><volume>6</volume><fpage>528</fpage><lpage>538</lpage><pub-id pub-id-type="doi">10.1097/QCO.0000000000000411</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Essid</surname><given-names>R</given-names></name><name><surname>Hammami</surname><given-names>M</given-names></name><name><surname>Gharbi</surname><given-names>D</given-names></name><etal/></person-group><article-title>Antifungal mechanism of the combination of Cinnamomum verum and Pelargonium graveolens essential oils with fluconazole against pathogenic <italic>Candida</italic> strains</article-title><source>Appl Microbiol Biotechnol</source><year>2017</year><volume>101</volume><fpage>6993</fpage><lpage>7006</lpage><pub-id pub-id-type="doi">10.1007/s00253-017-8442-y</pub-id><pub-id pub-id-type="pmid">28766033</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><mixed-citation publication-type="other">Swamy MK, Akhtar MS, Sinniah UR. Antimicrobial properties of plant essential oils against human pathogens and their mode of action: an updated review. Evid Based Complement Alternat Med. 2016:3012462.</mixed-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gucwa</surname><given-names>K</given-names></name><name><surname>Milewski</surname><given-names>S</given-names></name><name><surname>Dymerski</surname><given-names>T</given-names></name><name><surname>Szweda</surname><given-names>P</given-names></name></person-group><article-title>Investigation of the antifungal activity and mode of action of <italic>Thymus vulgaris</italic>, <italic>Citrus limonum</italic>, <italic>Pelargonium graveolens</italic>, <italic>Cinnamomum cassia</italic>, <italic>Ocimum basilicum</italic>, and <italic>Eugenia caryophyllus</italic> essential oils</article-title><source>Molecules</source><year>2018</year><volume>23</volume><fpage>E1116</fpage><pub-id pub-id-type="doi">10.3390/molecules23051116</pub-id><pub-id pub-id-type="pmid">29738503</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dos Santos</surname><given-names>JFS</given-names></name><name><surname>Rocha</surname><given-names>JE</given-names></name><name><surname>Bezerra</surname><given-names>CF</given-names></name><etal/></person-group><article-title>Chemical composition, antifungal activity and potential anti-virulence evaluation of the <italic>Eugenia uniflora</italic> essential oil against <italic>Candida</italic> spp</article-title><source>Food Chem</source><year>2018</year><volume>261</volume><fpage>233</fpage><lpage>239</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2018.04.015</pub-id><pub-id pub-id-type="pmid">29739588</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barreca</surname><given-names>D</given-names></name><name><surname>Lagan&#x000e0;</surname><given-names>G</given-names></name><name><surname>Leuzzi</surname><given-names>U</given-names></name><etal/></person-group><article-title>Evaluation of the nutraceutical, antioxidant and cytoprotective properties of ripe pistachio (<italic>Pistacia vera</italic> L., variety Bronte) hulls</article-title><source>Food Chem</source><year>2016</year><volume>196</volume><fpage>493</fpage><lpage>502</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2015.09.077</pub-id><pub-id pub-id-type="pmid">26593519</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bellocco</surname><given-names>E</given-names></name><name><surname>Barreca</surname><given-names>D</given-names></name><name><surname>Lagan&#x000e0;</surname><given-names>G</given-names></name><etal/></person-group><article-title>Cyanidin-3-<italic>O</italic>-galactoside in ripe pistachio (<italic>Pistachia vera</italic> L. variety Bronte) hulls: identification and evaluation of its antioxidant and cytoprotective activities</article-title><source>J Func Food</source><year>2016</year><volume>27</volume><fpage>376</fpage><lpage>385</lpage><pub-id pub-id-type="doi">10.1016/j.jff.2016.09.016</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smeriglio</surname><given-names>A</given-names></name><name><surname>Denaro</surname><given-names>M</given-names></name><name><surname>Barreca</surname><given-names>D</given-names></name><etal/></person-group><article-title>In vitro evaluation of the antioxidant, Cytoprotective, and antimicrobial properties of essential oil from <italic>Pistacia vera</italic> L. variety Bronte Hull</article-title><source>Int J Mol Sci</source><year>2017</year><volume>18</volume><fpage>E1212</fpage><pub-id pub-id-type="doi">10.3390/ijms18061212</pub-id><pub-id pub-id-type="pmid">28587291</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romeo</surname><given-names>O</given-names></name><name><surname>Criseo</surname><given-names>G</given-names></name></person-group><article-title>First molecular method for discriminating between <italic>Candida africana</italic>, <italic>Candida albicans</italic>, and <italic>Candida dubliniensis</italic> by using hwp1 gene</article-title><source>Diagn Microbiol Infect Dis</source><year>2008</year><volume>62</volume><fpage>230</fpage><lpage>233</lpage><pub-id pub-id-type="doi">10.1016/j.diagmicrobio.2008.05.014</pub-id><pub-id pub-id-type="pmid">18640803</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romeo</surname><given-names>O</given-names></name><name><surname>Scordino</surname><given-names>F</given-names></name><name><surname>Pernice</surname><given-names>I</given-names></name><etal/></person-group><article-title>A multiplex PCR protocol for rapid identification of Candida glabrata and its phylogenetically related species <italic>Candida nivariensis</italic> and Candida bracarensis</article-title><source>J Microbiol Methods</source><year>2009</year><volume>79</volume><fpage>117</fpage><lpage>120</lpage><pub-id pub-id-type="doi">10.1016/j.mimet.2009.07.016</pub-id><pub-id pub-id-type="pmid">19635503</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asadzadeh</surname><given-names>M</given-names></name><name><surname>Ahmad</surname><given-names>S</given-names></name><name><surname>Hagen</surname><given-names>F</given-names></name><etal/></person-group><article-title>Simple, low-cost detection of <italic>Candida parapsilosis</italic> complex isolates and molecular fingerprinting of <italic>Candida orthopsilosis</italic> strains in Kuwait by ITS region sequencing and amplified fragment length polymorphism analysis</article-title><source>PLoS One</source><year>2015</year><volume>10</volume><fpage>e0142880</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0142880</pub-id><pub-id pub-id-type="pmid">26580965</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>M&#x000fc;ller</surname><given-names>FM</given-names></name><name><surname>Werner</surname><given-names>KE</given-names></name><name><surname>Kasai</surname><given-names>M</given-names></name><etal/></person-group><article-title>Rapid extraction of genomic DNA from medically important yeasts and filamentous fungi by high-speed cell disruption</article-title><source>J Clin Microbiol</source><year>1998</year><volume>36</volume><fpage>1625</fpage><lpage>1629</lpage><?supplied-pmid 9620390?><pub-id pub-id-type="pmid">9620390</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><mixed-citation publication-type="other">Clinical and laboratory Standards Institute, Reference method for broth dilution antifungal susceptibility testing of yeasts, approved standard M27-A3, Clinical and laboratory standards institute, Wayne, Penn, USA, 3rd ed edition, 2008.</mixed-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>White</surname><given-names>RL</given-names></name><name><surname>Burgess</surname><given-names>DS</given-names></name><name><surname>Manduru</surname><given-names>M</given-names></name><name><surname>Bosso</surname><given-names>JA</given-names></name></person-group><article-title>Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E test</article-title><source>Antimicrob Agents Chemother</source><year>1996</year><volume>40</volume><fpage>1914</fpage><lpage>1918</lpage><pub-id pub-id-type="doi">10.1128/AAC.40.8.1914</pub-id><pub-id pub-id-type="pmid">8843303</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Filocamo</surname><given-names>A</given-names></name><name><surname>Bisignano</surname><given-names>C</given-names></name><name><surname>D'Arrigo</surname><given-names>M</given-names></name><etal/></person-group><article-title>Norfloxacin and ursolic acid: in vitro association and postantibiotic effect against Staphylococcus aureus</article-title><source>Lett Appl Microbiol</source><year>2011</year><volume>53</volume><fpage>193</fpage><lpage>197</lpage><pub-id pub-id-type="doi">10.1111/j.1472-765X.2011.03090.x</pub-id><pub-id pub-id-type="pmid">21609344</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Visalli</surname><given-names>MA</given-names></name><name><surname>Jacobs</surname><given-names>MR</given-names></name><name><surname>Appelbaum</surname><given-names>PC</given-names></name></person-group><article-title>Activities of three quinolones, alone and in combination with extended-spectrum cephalosporins or gentamicin, against <italic>Stenotrophomonas maltophilia</italic></article-title><source>Antimicrob Agents Chemother</source><year>1998</year><volume>42</volume><fpage>2002</fpage><lpage>2005</lpage><pub-id pub-id-type="doi">10.1128/AAC.42.8.2002</pub-id><pub-id pub-id-type="pmid">9687397</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><mixed-citation publication-type="other">International Standard ISO 22412:2017. Particle size analysis -- dynamic light scattering (DLS), International Organisation for Standardisation (ISO).</mixed-citation></ref><ref id="CR19"><label>19.</label><mixed-citation publication-type="other">MiLogP2.2, 2018. Molinspiration property calculation service FAQ, <ext-link ext-link-type="uri" xlink:href="http://www.molinspiration.com">http://www.molinspiration.com</ext-link>. Accessed June 2018.</mixed-citation></ref><ref id="CR20"><label>20.</label><mixed-citation publication-type="other">O&#x02019;Neill J. 2016. Tackling drug-resistant infections globally: final report and recommendations<bold>.</bold> London (UK): HM Government and the Wellcome Trust.</mixed-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leite</surname><given-names>MC</given-names></name><name><surname>de Brito Bezerra</surname><given-names>AP</given-names></name><name><surname>de Sousa</surname><given-names>JP</given-names></name><name><surname>de Oliveira Lima</surname><given-names>E</given-names></name></person-group><article-title>Investigating the antifungal activity and mechanism(s) of geraniol against <italic>Candida albicans</italic> strains</article-title><source>Med Mycol</source><year>2015</year><volume>53</volume><fpage>275</fpage><lpage>284</lpage><pub-id pub-id-type="doi">10.1093/mmy/myu078</pub-id><pub-id pub-id-type="pmid">25480017</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ebani</surname><given-names>VV</given-names></name><name><surname>Nardoni</surname><given-names>S</given-names></name><name><surname>Bertelloni</surname><given-names>F</given-names></name><etal/></person-group><article-title>Activity of <italic>Salvia dolomitica</italic> and <italic>Salvia somalensis</italic> essential oils against bacteria, molds and yeasts</article-title><source>Molecules</source><year>2018</year><volume>23</volume><fpage>E396</fpage><pub-id pub-id-type="doi">10.3390/molecules23020396</pub-id><pub-id pub-id-type="pmid">29438274</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bisignano</surname><given-names>C</given-names></name><name><surname>Filocamo</surname><given-names>A</given-names></name><name><surname>Faulks</surname><given-names>RM</given-names></name><name><surname>Mandalari</surname><given-names>G</given-names></name></person-group><article-title>In vitro antimicrobial activity of pistachio (<italic>Pistacia vera</italic> L.) polyphenols</article-title><source>FEMS Microbiol Lett.</source><year>2013</year><volume>341</volume><fpage>62</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1111/1574-6968.12091</pub-id><pub-id pub-id-type="pmid">23350629</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Filocamo</surname><given-names>A</given-names></name><name><surname>Bisignano</surname><given-names>C</given-names></name><name><surname>Mandalari</surname><given-names>G</given-names></name><name><surname>Navarra</surname><given-names>M</given-names></name></person-group><article-title>In Vitro Antimicrobial Activity and Effect on Biofilm Production of a White Grape Juice (<italic>Vitis vinifera</italic>) Extract</article-title><source>Evid Based Complement Alternat Med.</source><year>2015</year><volume>2015</volume><fpage>856243</fpage><pub-id pub-id-type="doi">10.1155/2015/856243</pub-id><pub-id pub-id-type="pmid">26770255</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><mixed-citation publication-type="other">Pal&#x000e1;-Pa&#x000fa;l, J, Usano-Alemany, J, Granda, E, Soria, AC: Chemical composition, antifungal and antibacterial activity of the essential oil of <italic>Chamaecyparis nootkatensis</italic> from Spain<bold>.</bold> Nat Prod Commun. 2009; 7:1007&#x02013;1010.</mixed-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castanheira</surname><given-names>M</given-names></name><name><surname>Deshpande</surname><given-names>LM</given-names></name><name><surname>Davis</surname><given-names>AP</given-names></name><name><surname>Rhomberg</surname><given-names>PR</given-names></name><name><surname>Pfaller</surname><given-names>MA</given-names></name></person-group><article-title>Monitoring Antifungal Resistance in a Global Collection of Invasive Yeasts and Molds: Application of CLSI Epidemiological Cutoff Values and Whole-Genome Sequencing Analysis for Detection of Azole Resistance in Candida albicans</article-title><source>Antimicrob Agents Chemother.</source><year>2017</year><volume>61</volume><fpage>e00906</fpage><lpage>e00917</lpage><?supplied-pmid 28784671?><pub-id pub-id-type="pmid">28784671</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Castro</surname><given-names>RD</given-names></name><name><surname>de Souza</surname><given-names>TMPA</given-names></name><name><surname>Bezerra</surname><given-names>LMD</given-names></name><name><surname>Ferreira</surname><given-names>GLS</given-names></name><name><surname>de Brito Costa</surname><given-names>EMM</given-names></name><name><surname>Leite Cavalcanti</surname><given-names>A</given-names></name></person-group><article-title>Antifungal activity and mode of action of thymol and its synergism with nystatin against Candida species involved with infections in the oral cavity: an in vitro study</article-title><source>BMC Complement Alter Med.</source><year>2015</year><volume>15</volume><fpage>417</fpage><pub-id pub-id-type="doi">10.1186/s12906-015-0947-2</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mandalari</surname><given-names>G</given-names></name><name><surname>Bisignano</surname><given-names>C</given-names></name><name><surname>D'Arrigo</surname><given-names>M</given-names></name><etal/></person-group><article-title>Antimicrobial potential of polyphenols extracted from almond skins</article-title><source>Lett Appl Microbiol</source><year>2010</year><volume>51</volume><fpage>83</fpage><lpage>89</lpage><?supplied-pmid 20497495?><pub-id pub-id-type="pmid">20497495</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bernardi</surname><given-names>D</given-names></name><name><surname>Pereira</surname><given-names>S</given-names></name><name><surname>Maciel</surname><given-names>TA</given-names></name><etal/></person-group><article-title>Formation and stability of oil-in-water nanoemulsions containing rice bran oil: in vitro and in vivo assessments</article-title><source>J Nanobiotechnology</source><year>2011</year><volume>9</volume><fpage>44</fpage><pub-id pub-id-type="doi">10.1186/1477-3155-9-44</pub-id><pub-id pub-id-type="pmid">21952107</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Dong</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><etal/></person-group><article-title>Design and optimization of a new self-nanoemulsifying drug delivery system</article-title><source>J Colloid Interface Sci</source><year>2009</year><volume>330</volume><fpage>443</fpage><lpage>448</lpage><pub-id pub-id-type="doi">10.1016/j.jcis.2008.10.077</pub-id><pub-id pub-id-type="pmid">19038395</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Solans</surname><given-names>C</given-names></name><name><surname>Sol&#x000e9;</surname><given-names>I</given-names></name></person-group><article-title>Nano-emulsions: formation by low-energy methods</article-title><source>Curr Opin Colloid Interface Sci</source><year>2012</year><volume>17</volume><fpage>246</fpage><lpage>254</lpage><pub-id pub-id-type="doi">10.1016/j.cocis.2012.07.003</pub-id></element-citation></ref></ref-list></back></article>